The Innovative Licensing and Access Pathway (ILAP) focuses on getting the most transformative new medicines to patients in the UK health system quickly.

You will:
• Read applications, judge how well the product meets the criteria and complete a form to capture your views

• Attend virtual meetings (MS Teams), take part in the discussions to contribute to decisions about which applications will enter the pathway

• Work alongside experts from the NHS, MHRA and HTAs